DSGN
Price
$3.14
Change
-$0.26 (-7.65%)
Updated
Apr 7 closing price
Capitalization
178.23M
34 days until earnings call
KRYS
Price
$166.01
Change
-$5.29 (-3.09%)
Updated
Apr 7 closing price
Capitalization
4.79B
34 days until earnings call
Ad is loading...

DSGN vs KRYS

Header iconDSGN vs KRYS Comparison
Open Charts DSGN vs KRYSBanner chart's image
Design Therapeutics
Price$3.14
Change-$0.26 (-7.65%)
Volume$208.77K
Capitalization178.23M
Krystal Biotech
Price$166.01
Change-$5.29 (-3.09%)
Volume$515.57K
Capitalization4.79B
DSGN vs KRYS Comparison Chart
Loading...
DSGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KRYS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DSGN vs. KRYS commentary
Apr 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DSGN is a Buy and KRYS is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 08, 2025
Stock price -- (DSGN: $3.14 vs. KRYS: $171.30)
Brand notoriety: DSGN and KRYS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DSGN: 142% vs. KRYS: 159%
Market capitalization -- DSGN: $178.23M vs. KRYS: $4.79B
DSGN [@Biotechnology] is valued at $178.23M. KRYS’s [@Biotechnology] market capitalization is $4.79B. The market cap for tickers in the [@Biotechnology] industry ranges from $283.55B to $0. The average market capitalization across the [@Biotechnology] industry is $2.07B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DSGN’s FA Score shows that 0 FA rating(s) are green whileKRYS’s FA Score has 1 green FA rating(s).

  • DSGN’s FA Score: 0 green, 5 red.
  • KRYS’s FA Score: 1 green, 4 red.
According to our system of comparison, KRYS is a better buy in the long-term than DSGN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DSGN’s TA Score shows that 5 TA indicator(s) are bullish while KRYS’s TA Score has 4 bullish TA indicator(s).

  • DSGN’s TA Score: 5 bullish, 6 bearish.
  • KRYS’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, both DSGN and KRYS are a bad buy in the short-term.

Price Growth

DSGN (@Biotechnology) experienced а -18.65% price change this week, while KRYS (@Biotechnology) price change was -6.86% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -9.46%. For the same industry, the average monthly price growth was -17.70%, and the average quarterly price growth was -17.86%.

Reported Earning Dates

DSGN is expected to report earnings on May 12, 2025.

KRYS is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (-9.46% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KRYS($4.8B) has a higher market cap than DSGN($178M). KRYS YTD gains are higher at: 9.345 vs. DSGN (-49.109). KRYS has higher annual earnings (EBITDA): 110M vs. DSGN (-61.79M). KRYS has more cash in the bank: 598M vs. DSGN (245M). DSGN has less debt than KRYS: DSGN (2.33M) vs KRYS (7.26M). KRYS has higher revenues than DSGN: KRYS (291M) vs DSGN (0).
DSGNKRYSDSGN / KRYS
Capitalization178M4.8B4%
EBITDA-61.79M110M-56%
Gain YTD-49.1099.345-526%
P/E RatioN/A55.31-
Revenue0291M-
Total Cash245M598M41%
Total Debt2.33M7.26M32%
FUNDAMENTALS RATINGS
KRYS: Fundamental Ratings
KRYS
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
79
Overvalued
PROFIT vs RISK RATING
1..100
16
SMR RATING
1..100
67
PRICE GROWTH RATING
1..100
52
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DSGNKRYS
RSI
ODDS (%)
Bullish Trend 5 days ago
85%
Bearish Trend 5 days ago
77%
Stochastic
ODDS (%)
Bullish Trend 5 days ago
87%
Bullish Trend 5 days ago
82%
Momentum
ODDS (%)
Bearish Trend 5 days ago
80%
Bearish Trend 5 days ago
77%
MACD
ODDS (%)
Bearish Trend 5 days ago
82%
Bearish Trend 5 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 5 days ago
83%
Bearish Trend 5 days ago
73%
TrendMonth
ODDS (%)
Bearish Trend 5 days ago
84%
Bearish Trend 5 days ago
75%
Advances
ODDS (%)
Bullish Trend 12 days ago
88%
Bullish Trend 21 days ago
76%
Declines
ODDS (%)
Bearish Trend 5 days ago
85%
Bearish Trend 5 days ago
76%
BollingerBands
ODDS (%)
Bullish Trend 5 days ago
79%
Bullish Trend 5 days ago
87%
Aroon
ODDS (%)
Bullish Trend 5 days ago
86%
Bullish Trend 5 days ago
76%
View a ticker or compare two or three
Ad is loading...
DSGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KRYS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
IBHJ26.000.28
+1.09%
iShares iBonds 2030 Term Hi Yld & IncETF
HYGI26.15-0.48
-1.81%
iShares Inflation Hedged Hgh Yld Bd ETF
TEAF11.02-0.37
-3.25%
Ecofin Sustainable and Social Impact Term Fund
MDYV69.51-3.40
-4.66%
SPDR® S&P 400 Mid Cap Value ETF
STK25.05-1.84
-6.84%
Columbia Seligman Premium Technology Growth Fund

KRYS and

Correlation & Price change

A.I.dvisor indicates that over the last year, KRYS has been loosely correlated with IDYA. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if KRYS jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KRYS
1D Price
Change %
KRYS100%
-3.83%
IDYA - KRYS
52%
Loosely correlated
-5.52%
ACLX - KRYS
52%
Loosely correlated
-6.17%
CRNX - KRYS
49%
Loosely correlated
-6.86%
PRME - KRYS
46%
Loosely correlated
-12.42%
ZLDPF - KRYS
45%
Loosely correlated
-8.90%
More